Searchable abstracts of presentations at key conferences on calcified tissues
Previous issue | Volume 3 | ECTS2014 | Next issue

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

Card image cap
European Calcified Tissue Society Annual Congress, 17 - 20 May 2014; Prague, Czech Republic

Oral Communications

Important pathways in bone biology and cancer

Regulation of bone metastasis by the IKK[beta]/FoxO3a axis
1Bone and Cancer Group, ECRC, IGMM, University of Edinburgh, Edinburgh, UK; 2Rheumatic Disease Unit, MMC, IGMM, University of Edinburgh, Edinburgh, UK; 3Galapagos SASU, Romainville, France; 4Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy; 5Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy.
ba0003oc5.2
Beta haemoglobin (hbb) is a novel marker of breast cancer progression
1Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy; 2Department of Pathology, San Salvatore Hospital, L’Aquila, Italy.
ba0003oc5.3
WNT5A has anti-prostate cancer effects and protects against bone metastases
1Division of Endocrinology, Diabetes, and Bone Diseases; Department of Medicine III, Technical University Dresden, Dresden, Germany; 2Department of Pathology, Technical University of Dresden, Dresden, Germany; 3Department of Urology, Technical University of Dresden, Dresden, Germany; 4Max Bergmann Center of Biomaterials, Technical University, Dresden, Germany; 5University of Würzburg, Orthopedic Center for Musculoskeletal Research, Würzburg, Germany; 6Center for Regenerative Therapies Dresden, Dresden, Germany.
ba0003oc5.4
Rs55710688 in the Kozak sequence of WNT16 increases translation efficiency and is associated with osteoporosis related parameters
1Department of Medical Genetics, University of Antwerp, Antwerp, Belgium; 2Department of Endocrinology, Odense University Hospital, Odense, Denmark.
ba0003oc5.5
Enhanced load adaptation in long bone of cathepsin K-deficient mice
1Service des Maladies Osseuses, Hôpitaux Universitaires, Genève, Geneva, Switzerland; 2Merck & Co., Whitehouse Station, New Jersey, USA.
ba0003oc5.6